Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Here, we study the intricate relationship between gut microbiota and host cometabolic phenotypes associated with dietary-induced impaired glucose homeostasis and nonalcoholic fatty liver disease (NAFLD) in a mouse strain (129S6) known to be susceptible to these disease traits, using plasma and urine metabotyping, achieved by (1)H NMR spectroscopy. Multivariate statistical modeling of the spectra shows that the genetic predisposition of the 129S6 mouse to impaired glucose homeostasis and NAFLD is associated with disruptions of choline metabolism, i.e., low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trimethylamine, and trimethylamine-N-oxide), coprocessed by symbiotic gut microbiota and mammalian enzyme systems. Conversion of choline into methylamines by microbiota in strain 129S6 on a high-fat diet reduces the bioavailability of choline and mimics the effect of choline-deficient diets, causing NAFLD. These data also indicate that gut microbiota may play an active role in the development of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal role for the involvement of gut microbes is in part based on the fulfillment of one of Koch’s postulates - namely, the transmission of a disease related phenotype with transplantation of gut microbial organisms to a new host (Cho and Blaser, 2012; Cox et al., 2014; Dumas et al., 2006; Gregory et al., 2015; Koch, 1880; Sandhu and Chase, 1986).”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Dumas et al., 2006
In the citing paper
“Interestingly, dysbiotic microbiota from mice fed a high-fat diet metabolize and convert dietary choline into methylamines, resulting in low circulating levels of plasma phosphatidylcholine60.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [60]
In the citing paper
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [39]
In the citing paper
“It has been demonstrated that the gut microbiota can play a role in the development of metabolic abnormalities such as insulin resistance and nonalcoholic fatty liver disease76,77.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [77]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citation
Research works printed but not linked: 2
- A. L. Buchman, M. D. Dubin, A. A. Moukarzel, D. J. Jenden, M. Roch, K. M. Rice, J. Gornbein, M. E. Ament Hepatology 22, 1399–1403 (1995).
- S. H. Zeisel, J. S. Wishnok, J. K. Blusztajn J. Pharmacol. Exp. Ther. 225, 320–324 (1983).
Cited by
Items 501–600 of 942
Microbiota and nonalcoholic steatohepatitis
Imajo, K., Yoneda, M., Ogawa, Y., Wada, K., & Nakajima, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0404-6 · Cited by 45
The role of microbiota in nonalcoholic fatty liver disease
Ciaula, A. D., Bonfrate, L., & Portincasa, P. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13768 · Cited by 46
The Genetic Architecture of Coronary Artery Disease: Current Knowledge and Future Opportunities
Hartiala, J., Schwartzman, W. S., Gabbay, J., Ghazalpour, A., Bennett, B. J., & Allayee, H. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0641-6 · Cited by 47
Zhu, Y. G., Bai, J., Zhang, Y., Xiao, X., & Dong, Y. (2016) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1197185 · Cited by 42
“Gut microbiota may play an active role in the development of diabetes (Dumas et al. 2006), and gut microbiota-derived LPS is the primum movens in the early development of inflammation and diabetes (Cani et al. 2007).”
BackgroundCOMPANION ANIMALS SYMPOSIUM: Role of microbes in canine and feline health1
Kil, D. Y., & Swanson, K. S. (2010) · Journal of Animal Science · doi:10.2527/jas.2010-3498 · Cited by 49
Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases
Schabussová, I., & Wiedermann, U. (2008) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328317b88b · Cited by 40
Xue, C., Lv, H., Li, Y., Dong, N., Wang, Y., Zhou, J., Shi, B., & Shan, A. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11410 · Cited by 51
Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders
Rajani, C., & Jia, W. P. (2018) · Clinical Science · doi:10.1042/cs20171328 · Cited by 45
Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections
Sérino, M. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.010 · Cited by 43
Nutritional impact on the plasma metabolome of rats.
Mellert, W., Kapp, M. N., Strauss, V., Wiemer, J., Kamp, H., Walk, T., Looser, R., Prokoudine, A., Fabian, E., Krennrich, G., et al. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.08.013 · Cited by 38
Thompson, C. L., Hofer, M. J., Campbell, I. L., & Holmes, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010335 · Cited by 42
“There is experimental evidence that the integration of microbial activity into host metabolism, in conjunction with maintenance of individual community differences, gives rise to microbiota-linked phenotypes [7–9] including obesity [10] and drug response [11,12].”
BackgroundCobbold, J., Anstee, Q. M., Goldin, R. D., Williams, H. R. T., Matthews, H. C., North, B. V., Absalom, N. L., Thomas, H. C., Thursz, M. R., Cox, R., et al. (2008) · Clinical Science · doi:10.1042/cs20080159 · Cited by 34
“These findings are consistent with reports of low plasma PtC and high urinary choline oxidation products seen in 129S6 mice fed HFD[10].”
ResultCiavarella, A., Gnocchi, D., Custodero, C., Lenato, G. M., Fiore, G., Sabbà, C., & Mazzocca, A. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.12.002 · Cited by 46
Metabolomic analysis of quorum sensing inhibitor hordenine on Pseudomonas aeruginosa
Zhou, J., Junaid, M., Bing, S., Yang, R., Wadood, A., Wang, J., & Jia, A. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09878-w · Cited by 46
Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease
Abdul‐Hai, A., Abdallah, A., & Malnick, S. D. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i12.1679 · Cited by 44
Cai, H., Wen, Z., Zhao, L., Yu, D., Meng, K., & Yang, P. (2022) · Food & Nutrition Research · doi:10.29219/fnr.v66.7974 · Cited by 43
“Our research is consistent with the studies that reducing the bioavailability of choline could result in NAFLD both in mice (25) and in humans (26).”
ResultEffects of chronic cadmium exposure at food limitation-relevant levels on energy metabolism in mice
He, X., Qi, Z., Hou, H., Gao, J., & Zhang, X. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121791 · Cited by 40
Physiological functions of urea transporter B
Yu, L., Liu, T., Fu, S., Li, L., Meng, X., Su, X., Xie, Z., Ren, J., Meng, Y., Lv, X., et al. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02323-x · Cited by 40
The Role of the Human Microbiome in Chemical Toxicity
Koontz, J. M., Dancy, B. C. R., Horton, C. L., Stallings, J. D., DiVito, V. T., & Lewis, J. A. (2019) · International Journal of Toxicology · doi:10.1177/1091581819849833 · Cited by 51
Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics
Cho, M. S., Kim, S. Y., Suk, K. T., & Kim, B. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-8346-2 · Cited by 46
Gut microbiota: An environmental risk factor for cardiovascular disease
Stock, J. K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.019 · Cited by 37
“Indeed, recent evidence has implicated the gut microbiota in insulin resistance and non-alcoholic fatty-liver disease [1,2].”
BackgroundLehtonen, H.-M., Lindstedt, A., Järvinen, R., Sinkkonen, J., Graça, G., Viitanen, M. H., Kallio, H. P. T., & Gil, A. M. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.10.081 · Cited by 41
Effect of Lactobacillus plantarum LP‐Onlly on gut flora and colitis in interleukin‐10 knockout mice
Xia, Y., Chen, H., Zhang, M., Jiang, Y., Hang, X., & Qin, H. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06498.x · Cited by 39
Reshef, N., Gophna, U., Reshef, L., Konikoff, F. M., Gabay, G., Zornitzki, T., Knobler, H., & Maor, Y. (2024) · Nutrients · doi:10.3390/nu16111571 · Cited by 37
“Increased production of TMAO reduces choline levels, resulting in a decrease in choline, consequently affecting the export of hepatic very-low-density lipoproteins and modulation of BA synthesis [12,14,15].”
BackgroundRecent review on selected xenobiotics and their impacts on gut microbiome and metabolome
Jin, Y., Chi, J., LoMonaco, K., Boon, A., & Gu, H. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117155 · Cited by 39
Insulin resistance in Alzheimer’s disease: The genetics and metabolomics links
Amin, A. M., Mostafa, H. M. A., & Khojah, H. M. J. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.016 · Cited by 52
Human Gut Microbiome and Liver Diseases: From Correlation to Causation
Li, R., Mao, Z., Ye, X., & Zuo, T. (2021) · Microorganisms · doi:10.3390/microorganisms9051017 · Cited by 43
Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk
Meyer, K. A., & Bennett, B. J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0791-x · Cited by 38
“A growing literature supports a role for gut microbiota in the development and progression of metabolic and cardiovascular disease risk[13–16], including type 2 diabetes[17–19], obesity[20–22], insulin resistance[23], inflammation[24], atherosclerosis[12, 25], hypertension[26, 27], dyslipidemia[28], and cardiovascular…”
BackgroundCholine metabolites: gene by diet interactions
Smallwood, T., Allayee, H., & Bennett, B. J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000259 · Cited by 42
A GC-MS metabolic profiling study of plasma samples from mice on low- and high-fat diets.
Spagou, K., Theodoridis, G., Wilson, I., Raikos, N., Greaves, P., Edwards, R., Nolan, B., & Klapa, M. (2011) · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · doi:10.1016/j.jchromb.2011.01.028 · Cited by 35
Microbiota and epigenetics: promising therapeutic approaches?
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15623-6 · Cited by 47
“The metabolites of choline lead not only to the inability to synthesize phosphatidylcholine, to the accumulation of triglycerides in the liver, but also to cardiovascular disease (CVD) (Corbin and Zeisel 2012; Drenick et al. 1982; Dumas et al. 2006; Wang et al. 2011).”
BackgroundPark, G. S. H., Jung, S., Wellen, K. E., & Jang, C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00614-x · Cited by 39
Association between metabolic profile and microbiomic changes in rats with functional dyspepsia
Luo, L., Hu, M., Li, Y., Chen, Y., Zhang, S., Chen, J., Wang, Y., Lu, B., Xie, Z., & Liao, Q. (2018) · RSC Advances · doi:10.1039/c8ra01432a · Cited by 42
Vinke, P. C., Aidy, S. E., & van Dijk, G. (2017) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00034 · Cited by 46
“Trimethylamine, for example, is the product of microbiota-dependent choline (essential dietary nutrient) metabolism (172).”
BackgroundNonalcoholic Fatty Liver Disease
Li, D., Yang, M., Edwards, S., & Ye, S. Q. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113481623 · Cited by 35
Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy
Klein, M. S., Dorn, C., Saugspier, M., Hellerbrand, C., Oefner, P. J., & Gronwald, W. (2010) · Metabolomics · doi:10.1007/s11306-010-0243-6 · Cited by 29
“Previous studies had reported only the successful discrimination of NAFLD from healthy controls in mice using NMR metabolite fingerprinting (Dumas et al. 2006), respectively of human NASH patients from controls on the basis of elevated urinary levels of neopterin (Yaman et al. 2005), an indicator…”
BackgroundInfluentialLi, X., Chen, Y., Liu, J., Yang, G., Zhao, J., Liao, G., Shi, M., Yuan, Y., He, S., Lu, Y., et al. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012157 · Cited by 33
Dao, M. C., Sokolovska, N., Brazeilles, R., Affeldt, S., Pelloux, V., Prifti, E., Chilloux, J., Verger, E. O., Kayser, B. D., Aron‐Wisnewsky, J., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01958 · Cited by 45
Self-citationSchlecht, I., Gronwald, W., Behrens, G., Baumeister, S. E., Hertel, J., Hochrein, J., Zacharias, H. U., Fischer, B., Oefner, P. J., & Leitzmann, M. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175133 · Cited by 38
The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases
Neves, A. L., Chilloux, J., Sarafian, M. H., Rahim, M. B. A., Boulangé, C. L., & Dumas, M.-E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.013 · Cited by 36
Self-citationCholine supplementation restores substrate balance and alleviates complications of Pcyt2 deficiency
Schenkel, L. C., Sivanesan, S., Zhang, J., Wuyts, B., Taylor, A., Verbrugghe, A., & Bakovic, M. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.05.014 · Cited by 39
“We also used H-NMR-based metabolomics [41–43] to identify additional plasma metabolic differences among WT, HET and HET− Cho mice.”
MethodMetabonomic characterization of early atherosclerosis in hamsters with induced cholesterol
Zha, W., Aa, J., Wang, G., Yan, B., Gu, S., Zhu, X., Hao, H., Huang, Q. B., Sun, J., Zhang, Y., et al. (2009) · Biomarkers · doi:10.1080/13547500903026401 · Cited by 32
Intestinal Ischemia/Reperfusion Injury: Defining the Role of the Gut Microbiome
Kinross, J. K., Warren, O. J., Basson, S., Holmes, E. C., Silk, D. B. A., Darzi, A. W., & Nicholson, J. K. (2009) · Biomarkers in Medicine · doi:10.2217/bmm.09.11 · Cited by 31
Self-citationLi, Y., Zhou, Y., Wang, L., Lin, X., Mao, M., Yin, S., Zhu, L., Jiao, Y., Yu, W., Gao, P., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.990953 · Cited by 36
“The second and third articles were published in PNAS and Hepatology, with 777 and 638 citations, respectively (25, 26).”
BackgroundImmune System Modulations by Products of the Gut Microbiota
Chénard, T., Prévost, K., Dubé, J., & Massé, É. (2020) · Vaccines · doi:10.3390/vaccines8030461 · Cited by 44
Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease
Sharpton, S. R., Yong, G. J. M., Terrault, N. A., & Lynch, S. V. (2018) · Hepatology Communications · doi:10.1002/hep4.1284 · Cited by 39
Morán‐Ramos, S., He, X., Chin, E. L., Tovar, A. R., Torres, N., Slupsky, C. M., & Raybould, H. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171672 · Cited by 44
“Choline can also be metabolized to trimethylamine (TMA) by gut microbiota followed by conversion to TMAO by the liver, increasing cardiovascular risk and limiting choline bioavailability [59, 60].”
BackgroundBäckhed, F. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04123.x · Cited by 35
Role of herbal medicine and gut microbiota in the prevention and treatment of obesity
Zhang, Q., Bai, Y., Wang, W., Li, J., Zhang, L., Tang, Y., & Yue, S. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116127 · Cited by 36
Krueger, E. S., Lloyd, T. S., & Tessem, J. S. (2021) · Nutrients · doi:10.3390/nu13082873 · Cited by 43
“In these models, over-nutrition induces disease phenotypes including increased hepatic lipogenesis rates, steatosis, serum aspartate transaminase or alanine transaminase levels, and insulin resistance, which are associated with elevated serum and urine TMAO levels [134,156].”
BackgroundFang, C., Du, H., Zheng, X., Zhao, A., Jia, W. P., & Xu, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201802306r · Cited by 39
“These results indicate thatALD, likemanyother metabolic disorders such as nonalcoholic fatty liver disease (59), type 2 diabetes (60), and cardiovascular disease (61), may be coordinately influenced by intestinal microbiome and metabolome.”
BackgroundHan, R., Ma, J., & Li, H. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0645-9 · Cited by 41
Data mining the human gut microbiota for therapeutic targets
Collison, M., Hirt, R. P., Wipat, A., Nakjang, S., Sanséau, P., & Brown, J. R. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs002 · Cited by 32
The use of probiotics and safety concerns: A review
Suresh Babu Naidu, K., Jamila, K. A., & Govender, P. (2012) · African Journal of Microbiology Research · doi:10.5897/ajmr12.1281 · Cited by 33
“…role in the development of numerous conditions including obesity (Clarke et al., 2012; Ley et al., 2006) diabetes (Bergman et al., 2006), non-alcoholic fatty liver disease (Dumas et al., 2006), inflammatory bowel diseases (Quigley, 2012; Strober et al., 2008), and cancer (Parvez et al., 2006).”
BackgroundMartin, F., Collino, S., & Rezzi, S. (2011) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.2810 · Cited by 29
Buchynskyi, M., Kamyshna, I., Halabitska, I., Petakh, P., Kunduzova, O., Oksenych, V., & Kamyshnyi, O. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1577724 · Cited by 30
Abdelhameed, F., Mustafa, A., Kite, C., Lagojda, L., Dallaway, A., Than, N. N., Kassi, E. N., Kyrou, I., & Randeva, H. S. (2025) · Livers · doi:10.3390/livers5010011 · Cited by 37
“Animal models have shown that higher rates of conversion of choline to TMA by the gut microbiota leads to reduced bioavailability of choline, resulting in hepatic inflammation and lipid accumulation mediated by lower VLDL levels [66,69].”
Lentil (Lens culinaris Medikus) Diet Affects the Gut Microbiome and Obesity Markers in Rat
Siva, N., Johnson, C. R., Richard, V., Jesch, E. D., Whiteside, W. S., Abood, A., Thavarajah, P., Duckett, S. K., & Thavarajah, D. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b03254 · Cited by 54
Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes
Pietzner, M., Budde, K., Homuth, G., Kastenmüller, G., Henning, A., Artati, A., Krumsiek, J., Völzke, H., Adamski, J., Lerch, M. M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00999 · Cited by 37
Wei, Y., Liang, M., Mai, K., Zheng, K., & Xu, H. (2016) · Aquaculture Nutrition · doi:10.1111/anu.12420 · Cited by 30
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
Gentilucci, U. V., Gallo, P., & Picardi, A. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.58831 · Cited by 37
“Moreover, a high-fat diet was demonstrated to promote the formation of the intestinal microbiota, which converts dietary choline into methylamines, reducing plasma phosphatidylcholine and producing effects similar to those of the choline-deficient diet, a well-validated experimental model of NASH [20, 21].”
BackgroundInfluentialEffects of dietary glucose supplementation on the fasted plasma metabolome in cats and dogs
Allaway, D., Kamlage, B., Gilham, M. S., Hewson, A. K., Wiemer, J. C., Colyer, A., & Rein, D. (2013) · Metabolomics · doi:10.1007/s11306-013-0527-8 · Cited by 34
Urinary Metabolic Phenotyping the slc26a6 (Chloride–Oxalate Exchanger) Null Mouse Model
García‐Pérez, I., Villaseñor, A., Wijeyesekera, A., Posma, J. M., Jiang, Z., Stamler, J., Aronson, P. S., Unwin, R. J., Barbas, C., Elliott, P., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr2012544 · Cited by 37
Self-citationLee, S. H., An, J. H., Park, H., & Jung, B. H. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.12.030 · Cited by 36
Rezzonico, E., Mestdagh, R., Delley, M., Combremont, S., Dumas, M., Holmes, E. C., Nicholson, J. K., & Bibiloni, R. (2011) · Gut Microbes · doi:10.4161/gmic.18754 · Cited by 27
Self-citationMunshi, S., Taneja, S., Bhavesh, N., Shastri, J., Aggarwal, R., & Jameel, S. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01488.x · Cited by 30
The Gut Microbiome and Pre-systemic Metabolism: Current State and Evolving Research
Grundmann, O. (2010) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000104 · Cited by 28
“Certain bacterial strains play a vital role in metabolism of nutrients such as choline or taurine; both of which are essential to the absorption of fatty acids by the host [15,29].”
BackgroundMicrobial factors in inflammatory diseases and cancers
Ong, H. S., & Yim, H. C. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_7 · Cited by 29
Hu, L., Brito, L. F., Abbas, Z., Sammad, A., Kang, L., Wang, D., Wu, H., Liu, A., Qi, G., Zhao, M., et al. (2021) · Animals · doi:10.3390/ani11092493 · Cited by 41
“Furthermore, we also observed that cold exposure influenced the excretion levels of 4-hydroxyphenylacetate, trimethylamine N-oxide, methanol, and hippurate, all of which are considered to be involved in the metabolism of the gut microbiome [37,56].”
BackgroundDepth-Dependent Differences in Community Structure of the Human Colonic Microbiota in Health
Lavelle, A., Lennon, G., Docherty, N. G., Balfe, Á., Mulcahy, H. E., Doherty, G. A., O’Donoghue, D. P., Hyland, J. M., Shanahan, F., Sheahan, K. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078835 · Cited by 32
“Conversely, the potential role of the microbiota in the etiology of conditions such as allergy and asthma [6], inflammatory bowel disease [7], colorectal cancer [8], irritable bowel syndrome [9], obesity/metabolic syndrome [10] and even regulation of the gut brain axis [11], is highly topical, while a close link betwe…”
Evaluating effects of penicillin treatment on the metabolome of rats
Sun, J., Schnackenberg, L. K., Khare, S., Yang, X., Greenhaw, J. J., Salminen, W. F., Mendrick, D. L., & Beger, R. D. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.05.030 · Cited by 31
Converging on a mechanism for choline degradation
Thibodeaux, C. J., & van der Donk, W. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219534110 · Cited by 28
Li, Y., Hu, W., Lin, B., Ma, T., Zhang, Z., Hu, W., Zhou, R., Kwok, L. Y., Sun, Z., Zhu, C., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2434675 · Cited by 35
Trimethylamine N-Oxide in Aquatic Foods
Li, X., Wang, C., Yanagita, T., Xue, C., Zhang, T., & Wang, Y. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01974 · Cited by 33
Depression-associated gut microbes, metabolites and clinical trials
Wang, M., Song, Z., Lai, S., Tang, F., Dou, L., & Yang, F. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1292004 · Cited by 35
Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms
Bakhshimoghaddam, F., & Alizadeh, M. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.05.012 · Cited by 32
Using Zebrafish to Investigate Interactions Between Xenobiotics and Microbiota
Catron, T. R., Gaballah, S., & Tal, T. L. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00203-7 · Cited by 27
Madrid-Gambín, F., Brunius, C. F., Garcia‐Aloy, M., Estruel‐Amades, S., Landberg, R., & Andrés‐Lacueva, C. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00047 · Cited by 36
Yin, C., Zhao, W., Liu, R., Liu, R., Wang, Z., Zhu, L. Y., Chen, W., & Liu, S. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.08.168 · Cited by 36
Tian, J., Xia, X.-T., Wu, Y., Zhao, L., Xiang, H., Du, G., Zhang, X., & Qin, X. (2016) · Scientific Reports · doi:10.1038/srep33820 · Cited by 36
Guo, W., Jiang, C., Liu, Y., Li, T., Liu, X., Jin, M., Qu, K., Chen, H., Jin, X., Liu, H., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00179 · Cited by 31
Palma, M., Hernández-Castellano, L. E., Castro, N., Henríquez, A. A., Capote, J., Matzapetákis, M., & de Almeida, A. M. (2016) · Molecular BioSystems · doi:10.1039/c5mb00851d · Cited by 36
Ding, L., Wang, D., Zhou, M., Du, L., Xu, J., Xue, C., & Wang, Y. (2016) · Journal of Oleo Science · doi:10.5650/jos.ess16005 · Cited by 33
Obesity, Asthma, and the Microbiome
Cho, Y., & Shore, S. A. (2016) · Physiology · doi:10.1152/physiol.00045.2015 · Cited by 37
Mohammed, A., & Guda, C. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s7-s16 · Cited by 42
“Thus conversion of dietary choline is used as a metabolic hallmark for liver and cardiovascular diseases [49].”
BackgroundAlteration of a Human Intestinal Microbiota under Extreme Life Environment in the Antarctica
Jin, J., Touyama, M., Yamada, S., Yamazaki, T., & Benno, Y. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00397 · Cited by 37
The colonic microflora and probiotic therapy in health and disease
Shanahan, F. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328340076f · Cited by 28
Differential protein abundance and function of UT-B urea transporters in human colon
Collins, D., Winter, D. C., Hogan, A. M., Schirmer, L., Baird, A. W., & Stewart, G. S. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00405.2009 · Cited by 37
“Recent studies have suggested that the microbial populations in our gastrointestinal tract differ greatly between individuals (7) and can have a significant effect on disease states, including diabetes (6), inflammatory bowel disease (14), and obesity (3).”
BackgroundBang, J.-W., Crockford, D. J., Holmes, E. C., Pazos, F., Sternberg, M. J. E., Muggleton, S., & Nicholson, J. K. (2008) · Journal of Proteome Research · doi:10.1021/pr070350l · Cited by 39
Self-citationYao, N., Yang, Y., Li, X., Wang, Y., Guo, R., Wang, X., Li, J., Xie, Z., Li, B., & Cui, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.906511 · Cited by 31
“Secondly, intestinal microorganisms have the ability to reduce the levels of choline, converting it into toxic methylamine which is associated with the risk of inducing hepatic steatosis (109).”
BackgroundRamireddy, L., Tsen, H., Chiang, Y.-C., Hung, C.-Y., Chen, F., & Yen, H. T. (2021) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2021.100043 · Cited by 39
“…including trimethylaminuria (fish-malodor syndrome), nonalcoholic fatty liver disease (NAFLD), chronic kidney diseases and colorectal cancer (Bae et al., 2014; Christodoulou, 2012; Dumas et al., 2006; Mendelsohn and Larrick, 2013; Tang and Hazen, 2014; Tang et al., 2015, 2013, Wang et al., 2011).”
BackgroundSu, Q., Guan, T., He, Y., & Lv, H. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00061 · Cited by 32
Ohtani, N. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0457-1 · Cited by 79
“We particularly fo - cused on the changes in the intestinal microbiota since it has been reportedly involved in obesity and nonalcoholic fatty liver disease ( NAFLD ) .”
A robust automatic phase correction method for signal dense spectra.
Bao, Q., Feng, J.-W., Chen, L., Chen, F., Liu, Z., Jiang, B., & Liu, C. (2013) · Journal of magnetic resonance (San Diego, Calif. 1997 : Print) · doi:10.1016/j.jmr.2013.06.012 · Cited by 27
Patel, N. R., McPhail, M. J. W., Shariff, M. I. F., Keun, H. C., & Taylor-Robinson, S. D. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.1 · Cited by 30
Cazier, J., Kaisaki, P. J., Argoud, K., Blaise, B. J., Veselkov, K., Ebbels, T. M. D., Tsang, T. M., Wang, Y., Bihoreau, M., Mitchell, S. C., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200566t · Cited by 25
Self-citationMechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases
Sun, J., Dudeja, P., & Xia, Y.-L. (2018) · Physiology in Health and Disease · doi:10.1007/978-1-4939-7534-1 · Cited by 27
“Excessive conversion of dietary choline into TMA by the gut microbiota, however, may reduce the bioavailability of choline to the host, which could impair very low-density lipoprotein secretion, increase accumulation of triglycerides in the liver, and promote hepatic steatosis (Dumas et al. 2006).”
BackgroundGut Microbiota Represent a Major Thermogenic Biomass
Riedl, R. A., Burnett, C. M.-L., Pearson, N. A., Reho, J. J., Mokadem, M., Edwards, R. A., Kindel, T. L., Kirby, J. R., & Grobe, J. L. (2021) · Function · doi:10.1093/function/zqab019 · Cited by 36
Safari, Z., Bruneau, A., Monnoye, M., Mariadassou, M., Philippe, C., Zatloukal, K., & Gérard, P. (2020) · Nutrients · doi:10.3390/nu12020287 · Cited by 46
“In recent years, it has been shown that the gut microbiota in C57 mice determines the susceptibility to develop NAFLD [21], and that the gut microbiota contributes to the different susceptibility to fatty liver of the BALB/c and 129S6 mouse strains [22].”
BackgroundBrochot, A., Azalbert, V., Landrier, J., Tourniaire, F., & Sérino, M. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900403 · Cited by 34
Metadata
- Authors
- Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- *Department of Biological Chemistry and
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-15
- Volume
- 103
- Issue
- 33
- Pages
- 12511-12516
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1567909
- OpenAlex
- W2139464173
- Cited by
- 1,042
- References
- 0
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 26 · 2022: 43 · 2021: 57 · 2020: 52 · 2019: 80 · 2018: 70 · 2017: 67 · 2016: 86 · 2015: 72 · 2014: 63 · 2013: 80 · 2012: 62
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (057733, 066786)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- gut microbiota, non-alcoholic fatty liver disease, insulin resistance, choline metabolism, phosphatidylcholine, trimethylamine N-oxide, methylamine, high-fat diet, impaired glucose homeostasis, metabotyping, host-microbe interactions, choline deficiency
- MeSH terms
- Animals, Body Weight, Dietary Fats, Fatty Liver, Glucose, Homeostasis, Insulin, Insulin Resistance, Lipids, Liver, Male, Methylamines, Mice, Inbred BALB C, Phenotype, Multivariate Analysis, Nuclear Magnetic Resonance, Biomolecular, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.